Day: July 10, 2020

CHARLOTTE, N.C., July 10, 2020 (GLOBE NEWSWIRE) — Coca-Cola Consolidated, Inc. (NASDAQ: COKE) announced that the Board of Directors has declared a dividend for the third quarter of 2020 of $0.25 per share on shares of the Company’s Common Stock and Class B Common Stock payable on August 7, 2020 to shareholders of record as of the close of business on July 24, 2020.About Coca-Cola Consolidated, Inc.Coke Consolidated is the largest Coca-Cola bottler in the United States. Our Purpose is to honor God, serve others, pursue excellence and grow profitably. For 118 years, we have been deeply committed to the consumers, customers, and communities we serve and passionate about the broad portfolio of beverages and services we offer. We make, sell, and deliver beverages of The Coca-Cola Company and other partner companies in more than...

MONTEBELLO, N.Y., July 10, 2020 (GLOBE NEWSWIRE) — Sterling Bancorp (NYSE: STL), the parent company of Sterling National Bank, today announced that it plans to release results for the second quarter ended June 30, 2020 after the market close on Wednesday, July 22, 2020.Jack Kopnisky, President and CEO of Sterling Bancorp, will host a teleconference and webcast on Thursday, July 23, 2020 at 8:00 AM Eastern Time to discuss the Company’s results. Analysts, investors and interested parties are invited to listen to the webcast and view accompanying slides on the Company’s website at www.sterlingbancorp.com or by dialing (800) 367-2403, Conference ID 7783050. The webcast will also be available at: https://event.webcasts.com/starthere.jsp?ei=1343746&tp_key=5f3aa17a1d. A replay of the teleconference can be accessed through the Company’s...

Not for distribution to United States newswire services or for dissemination in the United StatesVANCOUVER, British Columbia, July 10, 2020 (GLOBE NEWSWIRE) — SolidusGold Inc. (the “Company”) (TSX-V: “SDC”) announces the resignation of Steven Kahn as a director of the Company for personal reasons.“On behalf of the Company and the Board, I would like to thank Steve for serving on our Board over the past several years. Steve has been an integral part of Solidus from the beginning and we will miss his always balanced views and keen business sense. We wish him well all the best in his future endeavors,” said Rick Van Nieuwenhuyse, Chairman of the Board.Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or...

LOS ANGELES, July 10, 2020 (GLOBE NEWSWIRE) — Hanmi Financial Corporation (Nasdaq: HAFC) (“Hanmi”), the holding company for Hanmi Bank, today announced that it will report second quarter 2020 financial results at the market close on Tuesday, July 28, 2020. Management will host a conference call that same day, at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to discuss the results. Investment professionals and all current and prospective shareholders are invited to access the live call on July 28, 2020 by dialing 1-877-407-9039 before 2:00 p.m. Pacific Time, using access code HANMI. To listen to the call online, either live or archived, visit the Investor Relations page of Hanmi’s website at www.hanmi.com.About Hanmi Financial CorporationHeadquartered in Los Angeles, California, Hanmi Financial Corporation owns Hanmi Bank,...

MOUNTAIN GROVE, Mo., July 10, 2020 (GLOBE NEWSWIRE) — First Bancshares, Inc. (OTCPink – FstBksh: FBSI) (“Company”), the holding company for Stockmens Bank (“Bank”), today announced its financial results for the quarter ended June 30, 2020.For the quarter ended June 30, 2020, the Company reported net income, of $1,040,000 or $0.40 per share-diluted, compared to $835,000, or $0.33 per share diluted for the comparable period in 2019. The $205,000 increase in net income for the quarter ended June 30, 2020 compared to the quarter ended June 30, 2019 was attributable to a $949,000 increase in net interest income after provisions for loan losses, offset by a $547,000 decrease in non-interest income, a $84,000 increase in non-interest expense, and a $113,000 increase in income tax expense.Year to date net income ending June 30, 2020...

SAN FRANCISCO, July 10, 2020 (GLOBE NEWSWIRE) — Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the appointment of Elliott Sigal, M.D., Ph.D., to its board of directors. Dr. Sigal formerly served as Executive Vice President, Chief Scientific Officer and President of Bristol-Myers Squibb Company (BMS) Research and Development (R&D), where he played an instrumental role in bringing 14 new medicines to patients in need.“The Vir team is excited to welcome such an accomplished leader to our board of directors,” said George Scangos, Ph.D., chief executive officer of Vir. “Bringing more than 25 years of invaluable experience in the biopharmaceutical industry with him, Elliott will work with the other members of Vir’s board to guide the company as we advance our development pipeline to treat and prevent serious infectious diseases....

New York, July 10, 2020 (GLOBE NEWSWIRE) — Grayscale Investments, the world’s largest digital currency asset manager and manager of Grayscale® Digital Large Cap Fund (OTCQX: GDLC) (the Fund), today announced that the Fund will resume the private placement of its shares. The Fund’s private placement is offered on a periodic basis throughout the year and is currently available to accredited investors for daily subscription. About Grayscale Investments®  Grayscale Investments is the world’s largest digital currency asset manager, with more than $4.2B in assets under management as of July 9, 2020. Through its family of 10 investment products, Grayscale provides access and exposure to the digital currency asset class in the form of a traditional security without the challenges of buying, storing, and safekeeping digital currencies directly....

SAN FRANCISCO, July 10, 2020 (GLOBE NEWSWIRE) — Vir Biotechnology, Inc. (Nasdaq: VIR), a clinical-stage immunology company focused on treating and preventing serious infectious diseases, today announced the closing of its previously announced underwritten public offering of 8,214,285 shares of its common stock at a public offering price of $42.00 per share. This includes the exercise in full by the underwriters of their option to purchase up to 1,071,428 additional shares of common stock. The aggregate gross proceeds to Vir from the offering, before deducting the underwriting discounts and commissions and estimated offering expenses, were approximately $345.0 million.Goldman Sachs & Co. LLC, BofA Securities, Cowen and Barclays acted as joint book-running managers for the offering. Needham & Company acted as lead-manager...

AURORA, Ill., July 10, 2020 (GLOBE NEWSWIRE) — Westell Technologies, Inc. (NASDAQ:WSTL) today announced that a Special Committee of independent directors has recommended, and its Board of Directors has approved, a plan for a proposed transaction whereby the Company would effect a reverse/forward stock split of the Company’s shares of Class A Common Stock and Class B Common Stock, in conjunction with terminating the Company’s public company reporting obligations and delisting the Company’s Class A Common Stock from the NASDAQ Capital Market. It is expected that this transaction would be effectuated late in the third quarter or early in the fourth quarter of calendar year 2020, subject to stockholders approving the proposed transaction at the Annual Meeting of Stockholders.The Company is taking these steps to avoid the substantial...

–   People with diabetes are two times more likely to become infected with the hepatitis B virus (HBV) and up to four times as likely to get HBV-related liver cancer–   Hawaii has one of the highest rates of liver cancer in the U.S. and hepatitis B is a leading causeEMERYVIILLE, Calif., July 10, 2020 (GLOBE NEWSWIRE) — Dynavax Technologies Corporation, a biopharmaceutical company focused on developing and commercializing novel vaccines, and Times Pharmacy, have partnered with Hep Free Hawaii to provide HEPLISAV-B [Hepatitis B Vaccine (Recombinant), Adjuvanted] at pharmacy locations on Oahu, with a focus on people living with diabetes. Through this partnership, pharmacy customers will have access to HEPLISAV-B, the only FDA-approved two-dose hepatitis B vaccine for adults that is completed in one month. HEPLISAV-B is...